Petrus Trust Company, Lta Amneal Pharmaceuticals, Inc. Transaction History
Petrus Trust Company, Lta
- $984 Million
- Q1 2025
A detailed history of Petrus Trust Company, Lta transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 60,975 shares of AMRX stock, worth $495,726. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,975
Previous 60,975
-0.0%
Holding current value
$495,726
Previous $482,000
5.81%
% of portfolio
0.05%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$128 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$100 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$91.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$87.3 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$60.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.23B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...